flashContent
Company news

10 September 2020

Company Alkor Bio received registration certificate of Federal Service for Surveillance in Healthcare for the SARS-CoV-2EIA-IgG

On September 3, 2020 Company Alkor Bio received registration certificate of Federal Service for Surveillance in Healthcare for the SARS-CoV-2EIA-IgG.

03 August 2020

Alkor Bio Group of Companies received a registration certificate from Roszdravnadzor for the new kit of reagents "Intifica SARS-CoV-2" for the qualitative detection of SARS-CoV-2 coronavirus RNA by RT-PCR with fluorescence detection in real time

In  the middle of July, Alkor Bio Group of Companies received a registration certificate from Roszdravnadzor for the new kit of reagents "Intifica SARS-CoV-2" for the qualitative detection of SARS-CoV-2 coronavirus RNA by RT-PCR with fluorescence detection in real time.

 

 

10 April 2020

Alkor Bio Group of Companies has released two new reagents for molecular research: “Transport Media with Mucolytic” (TS-ML) and “Nuclease-free water”

TS-ML reagent is intended for collection, transportation and storage of clinical material for the subsequent nucleic acids isolation for PCR analysis. 

 

 

All news
Science news
All articles

Group "Alcor Bio" was established in 2007 on the basis of "Alcor Bio, the national leader in the manufacture of diagnostic products based on enzyme immunoassay.

In 2002, the company Alkor Bio "was singled company" Trans-Technologies, which specializes in studying the biology of human stem cells. On the basis of experimental data specialists are developing new methods of treatment of various diseases using stem cells.

OOO "Diagnostic Centers Alkor Bio provides the population of St. Petersburg laboratory diagnostic services. Besides DC Alkor Bio "is a clinical testing ground for clinical validation of diagnostic products manufactured by Company Alkor Bio.